HADC regulates the diabetic vascular endothelial dysfunction by targetting MnSOD

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Endocrinology

Background:

• Diabetic vascular dysfunction is a significant clinical issue.
• The precise molecular mechanisms driving this dysfunction remain incompletely understood.
• Endothelial cells (ECs) are central to vascular health and are profoundly affected by diabetes.

Purpose of the Study:

• To investigate the role of histone deacetylase 2 (HDAC2) in diabetic vascular dysfunction.
• To elucidate the molecular mechanisms by which HDAC2 influences endothelial cell behavior under high glucose conditions.
• To determine the potential of targeting HDAC2 for therapeutic interventions in diabetic vascular complications.

Main Methods:

• Quantification of HDAC2 expression and activity in ECs from diabetic patients and mice.
• Assessment of HDAC2 effects on EC proliferation and apoptosis under high glucose.
• Analysis of reactive oxygen species (ROS) accumulation and antioxidant treatments.
• Investigation of HDAC2 binding to the MnSOD promoter and its impact on histone modifications.

Main Results:

• HDAC2 expression and activity are upregulated in diabetic ECs and by high glucose.
• HDAC2 knockdown impairs EC proliferation and enhances high glucose-induced apoptosis via apoptotic pathways.
• HDAC2 regulates high glucose-induced ROS accumulation, with antioxidants mitigating HDAC2's effects on apoptosis.
• HDAC2 directly represses Manganese Superoxide Dismutase (MnSOD) expression by altering histone acetylation.

Conclusions:

• HDAC2 plays a critical role in promoting endothelial dysfunction in diabetes.
• The HDAC2-MnSOD signaling pathway is a key mediator of oxidative stress, proliferation, and survival in ECs under high glucose.
• Targeting HDAC2 may offer a novel therapeutic strategy for managing diabetic vascular complications.